Best At-Home Migraine Devices for Acute Migraine Relief in 2026

Migraine treatment is personal. Medications are an important part of care for many people, but some adults also look for drug-free treatments that can be used at home. Neuromodulation devices use targeted electrical or magnetic stimulation rather than delivering migraine medication.

Several FDA-cleared devices are available for acute migraine treatment, with differences in prescription status, age indication, placement, treatment format, and availability. Cefaly is available without a prescription in the U.S., Canada, the EU, and other countries.

This guide reviews several established and newer at-home options. It is not an exhaustive list, and FDA clearance does not mean every device is appropriate for every person. A healthcare provider can help you compare indications, warnings, and treatment formats.

Key Takeaways

• Cefaly combines acute and preventive treatment in one reusable, forehead-worn e-TNS device for adults 18 and older
• Cefaly is prescription-free in the U.S., Canada, the EU, and other countries
• Other devices use different formats, including upper-arm wearables, handheld magnetic stimulation, headsets, neck-based stimulation, and app-controlled electrical stimulation
• Access and costs vary by device, region, insurance plan, replacement supplies, and manufacturer program
• Safety information is device-specific, so review the instructions for use and discuss individual medical questions with a qualified healthcare provider

Why Consider an At-Home Migraine Device?

At-home neuromodulation gives people another treatment format to discuss with their healthcare provider. These devices use targeted stimulation and can often be self-administered after the user follows the applicable instructions and access requirements.

The practical differences matter. Some devices are worn on the forehead or upper arm, while others are placed on the neck or back of the head. Some require a prescription, app, refill, or subscription. Others use a reusable ownership model with replacement supplies.

Some people use neuromodulation as part of a broader migraine treatment plan that also includes medication, lifestyle management, and provider-directed care. Each device has its own warnings, contraindications, and instructions, so no single safety or medication-interaction statement applies to every option.

1) Cefaly

Best For: Adults comparing a prescription-free, forehead-worn e-TNS device for acute migraine treatment and daily preventive treatment

Access: No prescription required in the U.S., Canada, the EU, and other countries

Treatment Format: Reusable forehead-worn device with a 60-minute Acute program and a 20-minute daily Prevent program

Cefaly uses external trigeminal nerve stimulation, or e-TNS. An adhesive electrode is positioned on the forehead between and just above the eyebrows, allowing the device to stimulate branches of the trigeminal nerve involved in migraine pain pathways.

How It Works

The device connects magnetically to an adhesive electrode. The user selects either the 60-minute Acute program for treatment during a migraine attack or the 20-minute Prevent program for daily preventive treatment. Stimulation intensity increases gradually and can be adjusted to a comfortable level.

Key Features

• FDA-cleared indications: Acute treatment of migraine with or without aura and preventive treatment of migraine in adults 18 and older
• Two treatment programs: 60-minute Acute and 20-minute daily Prevent
• Prescription-free access: Available without a prescription in the U.S., Canada, the EU, and other countries
• Reusable device model: The device is purchased once, while replacement electrodes are the primary recurring supply cost
• Cefaly app for treatment control, migraine tracking, reports, weather information, and compatible wearable integrations where available
• Free coaching and customer-support resources where available
• HSA/FSA eligible in the U.S., subject to applicable plan rules

The Cefaly Migraine Relief app, Cefaly Connected device, and coaching services are not yet available in the EU.

Cefaly Clinical Evidence

Cefaly has more than 20 years of research and has been evaluated in more than 12 clinical trials. In the ACME study, 79% of patients experienced a significant reduction in headache pain after one hour of Cefaly Acute treatment, 63% reported that pain decreased by half or more. Cefaly’s clinical studies also evaluate preventive treatment and migraine-related symptoms.

Cefaly does not cure migraine, and individual responses can vary.

Pricing and Access

• Device cost: $509 for Cefaly Connected, based on current U.S. website pricing
• Standard electrodes: $28 for a three-pack
• Hypoallergenic electrodes: $36 for a three-pack
• Prescription: Not required
• Recurring cost: Replacement electrodes, with an optional electrode subscription
• Payment support: HSA/FSA eligibility and financing options may be available

Prices, promotions, taxes, and regional availability can change. Check Cefaly’s website for current terms before purchasing.

90-Day Satisfaction Guarantee

If you are not satisfied with Cefaly, you can return the device for a refund within 90 calendar days of your product delivery date when purchased directly from the official website. The return policy concerns returns and refunds and does not guarantee a particular clinical result.

Why It Made the List

Cefaly earns the top position in this guide because it combines prescription-free access, acute and preventive treatment programs, a reusable ownership model, Cefaly-specific clinical evidence, and support tools in one migraine-focused system. It is particularly practical for adults who want one at-home device that can support both treatment during attacks and a daily preventive routine.

2) Nerivio

Best For: People comparing a prescribed, smartphone-controlled neuromodulation wearable that is positioned on the upper arm rather than the head or neck

Access: Prescription required

Treatment Format: Remote electrical neuromodulation wearable controlled through a smartphone app

Nerivio uses remote electrical neuromodulation, or REN. The device is worn on the upper arm and is controlled through a compatible smartphone app. Its FDA-cleared indication includes acute and preventive migraine treatment for patients ages 8 and older.

Key Comparison Points

• Upper-arm placement
• Smartphone-controlled treatment
• Prescription-based access
• Pediatric and adult age indication
• Manufacturer-specific treatment schedule and device-use limits

Clinical Evidence and Safety

This device uses a different neuromodulation approach and has its own FDA-cleared indication, age requirements, prescription status, treatment format, and manufacturer-provided safety information. A healthcare provider can help explain how those factors apply to an individual situation.

Why It Made the List

Nerivio represents the upper-arm REN category and offers a treatment format that avoids forehead, neck, or headset placement. Its prescription pathway and app-controlled design are important considerations when comparing day-to-day use.

3) SAVI Dual

Best For: People comparing a prescribed, handheld magnetic-stimulation device applied at the back of the head

Access: Prescription required

Treatment Format: Single-pulse transcranial magnetic stimulation, or sTMS

SAVI Dual uses brief magnetic pulses delivered through a handheld device positioned at the back of the head. It is intended for acute and preventive migraine treatment in adolescents ages 12 and older and adults under its applicable FDA-cleared indication.

Key Comparison Points

• Magnetic rather than electrical stimulation
• Handheld placement at the back of the head
• Prescription-based access
• Acute and preventive treatment format
• Manufacturer-specific pulse instructions

Clinical Evidence and Safety

This device uses a different neuromodulation approach and has its own FDA-cleared indication, age requirements, prescription status, treatment format, and manufacturer-provided safety information. A healthcare provider can help explain how those factors apply to an individual situation.

Why It Made the List

SAVI Dual provides a magnetic-stimulation format for people comparing sTMS with electrical neuromodulation approaches. Device handling, prescription access, and the required treatment routine should be reviewed before use.

4) Relivion MG

Best For: Adults comparing a prescription headset that stimulates branches of both the trigeminal and occipital nerves

Access: Prescription required

Treatment Format: External combined occipital and trigeminal neurostimulation through a head-worn device

Relivion MG uses a headset-style format with electrodes positioned around the front and back of the head. This differs from Cefaly’s smaller forehead-electrode design and from upper-arm, neck-based, or handheld magnetic options.

Key Comparison Points

• Headset-style placement
• Combined trigeminal and occipital nerve stimulation
• Prescription-based access
• App-supported treatment system
• Manufacturer-specific onboarding and pricing structure

Clinical Evidence and Safety

This device uses a different neuromodulation approach and has its own FDA-cleared indication, age requirements, prescription status, treatment format, and manufacturer-provided safety information. A healthcare provider can help explain how those factors apply to an individual situation.

Why It Made the List

Relivion MG represents the combined occipital-trigeminal category. Its broader head-worn format and prescription pathway may appeal to people specifically comparing headset-based treatment with smaller wearables.

5) gammaCore

Best For: People comparing a prescribed, handheld device that delivers non-invasive vagus nerve stimulation at the neck

Access: Prescription required

Treatment Format: Brief non-invasive vagus nerve stimulation sessions applied to the side of the neck

gammaCore uses non-invasive vagus nerve stimulation, or nVNS. The handheld device is placed on the neck and used according to the treatment schedule in its instructions for use. Its cleared indications, age requirements, dosing limits, and coverage pathways should be confirmed for the individual patient and condition.

Key Comparison Points

• Neck-based stimulation
• Handheld treatment format
• Prescription-based access
• Multiple manufacturer-specified indications
• Device-specific daily stimulation limits

Clinical Evidence and Safety

This device uses a different neuromodulation approach and has its own FDA-cleared indication, age requirements, prescription status, treatment format, and manufacturer-provided safety information. A healthcare provider can help explain how those factors apply to an individual situation.

Why It Made the List

gammaCore represents the nVNS category and differs substantially from forehead, upper-arm, headset, and magnetic-stimulation devices. People considering it should review the indication relevant to their diagnosis with a qualified provider.

6) Enso for Migraine

Best For: Adults comparing a newer over-the-counter, app-controlled electrical-stimulation system for acute and preventive migraine treatment

Access: Over the counter in the U.S. under its 2026 FDA clearance

Treatment Format: Wearable, app-controlled transcutaneous electrical nerve stimulation system with adhesive gel pads

The FDA cleared Enso for Migraine in April 2026 for acute treatment of migraine with or without aura and preventive treatment of migraine in adults 18 and older. The device is intended for people diagnosed with migraine by a physician. Its clearance confirms that Cefaly is not the only OTC migraine neuromodulation device in the U.S.

Key Comparison Points

• OTC access in the U.S.
• App-controlled electrical stimulation
• Acute and preventive indications for adults 18 and older
• Adhesive gel-pad system
• Newer availability, pricing, and support details may continue to develop

Clinical Evidence and Safety

This device uses a different neuromodulation approach and has its own FDA-cleared indication, age requirements, prescription status, treatment format, and manufacturer-provided safety information. A healthcare provider can help explain how those factors apply to an individual situation.

Why It Made the List

Enso is included because its April 2026 clearance changed the OTC migraine-device landscape. Adults comparing OTC options should review current commercial availability, instructions, replacement supplies, and support directly with the manufacturer.

Why Cefaly Stands Out for Accessibility and Dual-Mode Treatment

Cefaly combines prescription-free access, acute and preventive treatment modes, a reusable ownership model, and Cefaly-specific clinical evidence. These features make it a practical option for adults comparing drug-free, at-home migraine treatment formats.

Prescription-free access. Cefaly can be purchased without a prescription in the U.S., Canada, the EU, and other countries. This removes the prescription step, although people should still discuss new, changing, or unusual symptoms with a healthcare provider.

Dual-mode treatment. One device provides a 60-minute Acute program for treatment during a migraine attack and a 20-minute daily Prevent program. The treatment routine allows adults to use the same device for acute and preventive care.

Reusable ownership model. Cefaly uses an ownership model: the device is purchased once, while replacement electrodes are the primary recurring supply cost. Total cost still depends on current pricing, electrode use, discounts, taxes, financing, and individual circumstances.

Cefaly-specific evidence. Cefaly’s research includes acute and preventive clinical studies. The article does not compare Cefaly’s evidence quality or response rates with those of competing devices.

Tracking and support. The Cefaly app can support treatment control, migraine logging, reports, weather information, and compatible wearable integrations where available. Free one-on-one coaching sessions and customer-support resources are also available where offered. The app, Cefaly Connected device, and coaching services are not yet available in the EU.

Satisfaction guarantee. Eligible products purchased directly from the official website may be returned within 90 calendar days of delivery if the customer is not satisfied. This is a return-and-refund policy, not a guarantee of treatment effectiveness.

Safety and Provider Guidance

Cefaly is drug-free and does not introduce medication into the body. Each neuromodulation device has its own warnings, contraindications, and instructions for use.

Do not use Cefaly if you have metallic or electronic implants in the head, a cardiac pacemaker, an implanted or wearable defibrillator, or pain of unknown origin. Talk to your healthcare provider before using Cefaly if you are pregnant, breastfeeding, have an implanted device, have a complex medical history, are changing medications, or are experiencing new or unusual symptoms.

A Cefaly provider can offer Cefaly-specific education or an in-office demonstration where available. For questions about another prescription device, consult a qualified healthcare provider or the manufacturer’s authorized-provider network.

Frequently Asked Questions

Are at-home migraine devices safe?

Safety depends on the specific device, user, and medical history. Every device has its own contraindications, warnings, age requirements, placement instructions, and potential side effects. Review the manufacturer’s instructions and speak with a healthcare provider when you have an implanted device, are pregnant or breastfeeding, have a complex medical history, or develop new or unusual symptoms.

Can I use a migraine device with my current medications?

Do not assume one interaction statement applies to every neuromodulation device. Some people use device-based and medication-based treatments within the same migraine care plan, but medication changes and device selection should be discussed with the clinician managing your care.

Which device is best for someone new to neuromodulation?

The most suitable starting point depends on age, diagnosis, prescription requirements, placement preference, treatment schedule, regional availability, budget, insurance coverage, and medical history. Cefaly offers a straightforward prescription-free option for adults who want acute and preventive treatment in one reusable forehead-worn device.

Do insurance plans cover migraine devices?

Coverage varies by device, manufacturer program, region, and insurance plan. Cefaly is HSA/FSA eligible in the U.S., subject to plan rules, and financing options may be available. Contact the insurer and manufacturer to confirm current eligibility, reimbursement requirements, and out-of-pocket costs.

How do I know whether neuromodulation will work for me?

Individual responses vary. Review the device’s indication and treatment routine, use it according to the instructions, and track your experience over an appropriate period. Cefaly’s migraine tracking tools can help users document treatments and patterns where available. For questions about Cefaly, use the Cefaly-certified provider directory or contact customer support. For another prescription device, consult a qualified healthcare provider or the manufacturer’s authorized-provider network.